Golden
Nextbiotics

Nextbiotics

A biotechnology company, founded in 2017 and based in San Francisco, with a platform that enables viruses to be engineered for use as therapeutics against antibiotic-resistant bacteria.

Nextbiotics is a biotechnology and synthetic biology company headquartered in San Francisco, California that was founded in 2017 by Angie Carrillo, Jorge Bardales, an Maricel Saenz.



The company combines bacteriophage therapy (Phage therapy) with CRISPR technology to reverse antibiotic resistance.The engineered viruses will specifically target drug-resistant bacteria and generate double-strand breaks, destroying the drug resistant genes or the genomic DNA of the bacteria, which will kill the bacteria.





One of the founders, Dr. Jorge Bardales, has a Ph.D. in Biophysics from University of California Berkeley and worked in the lab of Jennifer Doudna, one of the original group of scientists that developed CRISPR as a biotechnology tool. 

Funding

Seed

On January 26, 2018 Nextbiotics completed their seed funding round with $100,000 in funding from Berkeley SkyDeck Fund. 

Timeline

January 26, 2018

Seed

On January 26, 2018 Nextbiotics completed their seed funding round with $100,000 in funding from Berkeley SkyDeck Fund. 

People

Name
Role
Related Golden topics

Angie Carrillo

Founder



Angie Carrillo Reluz

Founder



Jorge Bardales

Founder



Maricel Saenz

Founder



Further reading

Title
Author
Link
Type







Documentaries, videos and podcasts

Title
Date
Link

Global Solutions Program: NextBiotics | Maricel Saenz | SU Global Summit

October 5, 2007

Nextbiotics

October 21, 2017

Nextbiotics SU Global Summit 2017

August 22, 2017

Companies

Company
CEO
Location
Products/Services









References